Name Net increased
positions
Increased positions Reduced positions Return since
31 Dec ‘17
126
24 66 42 93.8%
127
24 119 95 6.89%
128
24 57 33 45.7%
LGND icon
129
Ligand Pharmaceuticals
LGND
$4B
24 123 99 138%
130
24 99 75 38.8%
131
23 112 89 24.9%
132
23 36 13 61.6%
133
23 77 54 151%
134
23 197 174 43.3%
135
23 55 32 152%
RGEN icon
136
Repligen
RGEN
$9.63B
23 78 55 371%
137
23 28 5 333%
138
23 78 55 138%
139
23 67 44 212%
140
23 94 71 19.4%
141
23 57 34 38.6%
142
23 82 59 98.2%
143
23 68 45 165%
144
23 275 252 83.9%
145
23 57 34 33.4%
146
23 61 38 5.37%
147
23 60 37 50.8%
148
23 97 74 3.5%
149
23 48 25 1.74%
150
23 84 61 72.8%